Bivalirudin versus UFH with or without GP IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction undergoing primary PCI
27 August 2016 (00:00 - 00:00)
Organised by:
About the speaker

Karolinska Institute, Stockholm (Sweden)
4 More presentations in this session


Doctor G. Giustino (New York, US)

Access the full session
The Event
ESC Congress 2016
27 August - 31 August 2016

